<?xml version="1.0" encoding="UTF-8"?>
<p id="p0095">A combination of interferon-α-2a with ribavirin was administered to patients with severe MERS-CoV infection and the survival of these patients was improved [
 <xref rid="bib87" ref-type="bibr">87</xref>]. During the SARS outbreak in 2003, Intravenous gammaglobulin (IVIg) was used extensively in Singapore. However, one-third of critically ill patients developed venous thromboembolism including pulmonary embolism despite the use of low-molecular-weight heparin prophylactic [
 <xref rid="bib88" ref-type="bibr">88</xref>]. Thymosin α-1 could increase resistance to glucocorticoid-induced death of the thymocyte [
 <xref rid="bib89" ref-type="bibr">89</xref>]. Thymosin α-1 could also be used as an immune enhancer to SARS patients and it was effective in controlling the spread of the disease [
 <xref rid="bib90" ref-type="bibr">90</xref>,
 <xref rid="bib91" ref-type="bibr">91</xref>]. Thymopentin (TP5, munox), a synthetic pentapeptide corresponding to the active site of thymopoietin, had been shown to restore antibody production in old mice [
 <xref rid="bib92" ref-type="bibr">92</xref>]. levamisole can act as either an immunostimulant agent or an immunosuppressive agent depending upon the dosing and the timing [
 <xref rid="bib93" ref-type="bibr">93</xref>]. Luo et al. [
 <xref rid="bib94" ref-type="bibr">94</xref>] had speculated that nucleocapsid protein (NP) of SARS-CoV played an important role in the process of virus particle assembly and release and it might also bind to human cyclophilin A.
</p>
